Note: We will be closed on May 30 for Memorial Day – shipping dates may be affected.
nanoComposix is now a Fortis Life Sciences Company. Learn more + Email Newsletter Signup

Bulk Gold Nanomaterials for Point of Care Diagnostics

Solutions to meet your performance, quality, cost, and scale requirements

As one of the world’s largest gold nanoparticles manufacturers,1 we can leverage our scaled production to provide the highest quality gold colloid and gold nanoshells for use in rapid diagnostic tests2 at competitive prices. Our facilities can support particle volumes to match the manufacturing of 30–50 million lateral flow strips per month and all materials are delivered with nanoComposix’s extensive characterization, ensuring consistent quality for your manufacturing needs.

Offering both traditional gold colloid for passive conjugation and gold nanoshells for high sensitivity solutions, nanoComposix has the right products for your assay’s needs. Contact us today to get a quote or learn more about how we can support your development and manufacturing requirements.

Why Choose Us

Case Studies

Sensitivity enhancement of food safety assay using gold nanoshells

Client: Global leader in the development of food safety detection technologies

To maintain their leadership position, the customer needed to improve the sensitivity of their assays and enable a higher degree of multiplexing. The customer evaluated multiple reporter particles and detection platforms without success prior to contacting nanoComposix. Using gold nanoshells from nanoComposix, the customer was able to achieve the required sensitivity and multiplexing performance and maintain their market leadership.

Bulk conjugate supply for infectious disease rapid diagnostic

Client: A high-capacity point-of-care diagnostic manufacturer

To support the development and commercial release of a rapid point-of-care diagnostic for SARS-COV-2, the customer required a supply of high-sensitivity custom gold conjugates at scale. nanoComposix developed and scaled a custom process to produce antibody-nanoshell conjugates, meeting the required sensitivity targets and production scale. Customer’s assay has received approval for use in Canada with additional approvals pending.

Related Products


Footnotes

  1. MarketWatch ↩︎
  2. GMP when paired with appropriate design controls, upon request ↩︎